Is NATR or NERV more undervalued in 2026?

CirclFi compares Nature's Sunshine Products, Inc (NATR) and Minerva Neurosciences, Inc (NERV) using 13 institutional-grade valuation models. NATR has a Quality of Company score of 8.8/10 while NERV scores 3.4/10.

Which is a better buy — NATR or NERV?

Compare intrinsic values from 13 independent models against current market prices. CirclFi also calculates Value Trap scores. This is not financial advice — conduct your own analysis.

How do NATR and NERV valuations compare?

NATR at $21.28 and NERV at $4.91 are compared across Bayesian DCF, EPV, EROIC Spread, First Chicago, Markov DDM, and 8 additional models.

NATR vs NERV Valuation Comparison 2026 — Intrinsic Value Analysis

NATR

Pharmaceutical Preparations

Nature's Sunshine Products, Inc

Quality

8.8

out of 10

Value Trap

SAFE

Price

$21.28

Last close

Models

13/13

Active

NERV

Pharmaceutical Preparations

Minerva Neurosciences, Inc

Quality

3.4

out of 10

Value Trap

SAFE

Price

$4.91

Last close

Models

6/13

Active

Model-by-Model Comparison

Model	Type	NATR Fair Value	NATR Upside	NERV Fair Value	NERV Upside
Bayesian DCF	Intrinsic	$19.61	-7.8%	$1.70	-65.3%
Earnings Power Value	Intrinsic	$14.30	-32.8%	—	—
EROIC Spread	Intrinsic	$•••.••	••.•%	$•••.••	••.•%
First Chicago	Scenario	$•••.••	••.•%	$•••.••	••.•%
Markov DDM	Intrinsic	$•••.••	••.•%	$•••.••	••.•%
ML-RIV	Intrinsic	$•••.••	••.•%	$•••.••	••.•%
Dynamic NAV	Asset-Based	$•••.••	••.•%	$•••.••	••.•%
PWERM	Option-Based	$24.47	+15.0%	$11.74	+139.1%
Regime Cross-Sectional	Relative	$•••.••	••.•%	$•••.••	••.•%
Sentiment SOTP	Hybrid	$•••.••	••.•%	$•••.••	••.•%
CUCE Ensemble	Ensemble	$•••.••	••.•%	$•••.••	••.•%
FTNN Topology	Relative	$•••.••	••.•%	$•••.••	••.•%
RCMH-DCF	Intrinsic	$•••.••	••.•%	$•••.••	••.•%

🔒

Unlock Full 13-Model Comparison

Access all valuation models for NATR vs NERV — including EROIC Spread, First Chicago, Markov DDM, PWERM, and 7 more.

Access Full Analysis — From $27/mo →

NATR vs NERV — Which Stock Is More Undervalued?

NATR scores higher with a 8.8/10 quality rating vs NERV's 3.4/10. Both stocks are analyzed daily using SEC EDGAR filings across 13 independent models.

Comparing Nature's Sunshine Products, Inc (NATR) and Minerva Neurosciences, Inc (NERV) across 13 institutional-grade valuation models reveals how each company's intrinsic value stacks up against its market price. CirclFi's engine processes SEC EDGAR 10-K and 10-Q filings, FRED macroeconomic data, and GDELT news sentiment to generate independent fair value estimates daily.

NATR currently trades at $21.28 with a QOC of 8.8/10, while NERV trades at $4.91 with a QOC of 3.4/10.

Both companies are analyzed with models spanning intrinsic (Bayesian DCF, EPV), scenario-based (First Chicago), regime-switching (Markov DDM, RCMH-DCF), machine learning (ML-RIV, FTNN Topology), and ensemble methods (CUCE).